Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
These medications are FDA-approved for diabetes or weight management, but their widespread use is generating a new demand for aesthetic support: clients achieving rapid weight loss are increasingly turning to medspas to help manage the visible, sometimes unexpected, effects of transformation
Various studies have attempted to quantify how much fat versus muscle mass is being lost when using GLP-1 agonists and the results vary anywhere from 20 to 50% of total weight loss as lean body mass (3) (muscle mass)
The standard Wegovy dosing schedule involves gradual escalation over 16 weeks, starting at 0.25 mg weekly and increasing to the maintenance dose of 2.4 mg weekly
Semaglutide , a groundbreaking GLP-1 receptor agonist, has transitioned remarkably from its initial role in managing Type 2 diabetes to a potent weapon in the fight against obesity
